Clinical Application of Ventricular Intracranial Pressure Monitoring in the Treatment of Ruptured Anterior Circulation Aneurysms: A Retrospective Study. [PDF]
Chen T, Guo X, Cai M.
europepmc +1 more source
Abstract Objective To highlight key factors required to optimize multi‐mechanistic approaches with oral combination treatments for the acute management of a migraine attack. Background Given the complex multi‐factorial nature of migraine, combining treatments with different mechanisms of action should improve outcomes compared to monotherapies, but ...
Stephen Silberstein, Alan M. Rapoport
wiley +1 more source
Post-craniotomy intracranial pressure monitoring: a novel approach combining optic nerve sheath diameter ultrasonography and cervical-cerebral arterial ultrasound. [PDF]
Fu Z +8 more
europepmc +1 more source
Abstract Objective Calcitonin gene‐related peptide (CGRP) inhibitors, including monoclonal antibodies (mAbs) and small‐molecule antagonists (gepants), have transformed migraine treatment. Although clinical trials established their efficacy and initial safety, post‐marketing surveillance is essential for understanding their real‐world safety profile in ...
Martina Giacon, Salvatore Terrazzino
wiley +1 more source
Intracranial Pressure Monitoring Location: A Pilot Study on the Validation of Subdural Site with the Intraventricular Site. [PDF]
Bharadwaj S +3 more
europepmc +1 more source
From indication to initiation of invasive intracranial pressure monitoring time differences between neurosurgeons and intensive care physicians: can intracranial hypertension dose be reduced? TIMING-ICP, a multicenter, observational, prospective study. [PDF]
Mariani L +23 more
europepmc +1 more source
Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of unknown aetiology [PDF]
Barnoon +17 more
core +1 more source
Abstract Autosomal polycystic kidney disease (ADPKD) is the most common form of inherited kidney disease. The international guideline developer, Kidney Disease: Improving Global Outcomes (KDIGO), published a 2025 clinical practice guideline reflecting advances in genetic testing and the first disease‐modifying agent, tolvaptan.
Mia E. Abdy +26 more
wiley +1 more source
Intracranial pressure monitoring for severe traumatic brain injury: A retrospective study of 273 consecutive patients. [PDF]
Limpastan K +7 more
europepmc +1 more source

